Literature DB >> 26112719

Different Eukaryotic Initiation Factor 2Bε Mutations Lead to Various Degrees of Intolerance to the Stress of Endoplasmic Reticulum in Oligodendrocytes.

Na Chen, Yu-Wu Jiang, Hong-Jun Hao, Ting-Ting Ban, Kai Gao, Zhong-Bin Zhang, Jing-Min Wang, Ye Wu1.   

Abstract

BACKGROUND: Vanishing white matter disease (VWM), a human autosomal recessive inherited leukoencephalopathy, is due to mutations in eukaryotic initiation factor 2B (eIF2B). eIF2B is responsible for the initiation of protein synthesis by its guanine nucleotide exchange factor (GEF) activity. Mutations of eIF2B impair GEF activity at different degree. Previous studies implied improperly activated unfolded protein response (UPR) and endoplasmic reticulum stress (ERS) participated in the pathogenesis of VWM. Autophagy relieves endoplasmic reticulum load by eliminating the unfolded protein. It is still unknown the effects of genotypes on the pathogenesis. In this work, UPR and autophagy flux were analyzed with different mutational types.
METHODS: ERS tolerance, reflected by apoptosis and cell viability, was detected in human oligodendrocyte cell line transfected with the wild type, or different mutations of p. Arg113His, p. Arg269FNx01 or p. Ser610-Asp613del in eIF2Bε. A representative UPR-PERK component of activating transcription factor 4 (ATF4) was measured under the basal condition and ERS induction. Autophagy was analyzed the flux in the presence of lysosomal inhibitors.
RESULTS: The degree of ERS tolerance varied in different genotypes. The truncated or deletion mutant showed prominent apoptosis cell viability declination after ERS induction. The most seriously damaged GEF activity of p. Arg269FNx01 group underwent spontaneous apoptosis. The truncated or deletion mutant showed elevated ATF4 under basal as well as ERS condition. Decreased expression of LC3-I and LC3-II in the mutants reflected an impaired autophagy flux, which was more obvious in the truncated or deletion mutants after ERS induction.
CONCLUSIONS: GEF activities in different genotypes could influence the cell ERS tolerance as well as compensatory pathways of UPR and autophagy. Oligodendrocytes with truncated or deletion mutants showed less tolerable to ERS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26112719      PMCID: PMC4733711          DOI: 10.4103/0366-6999.159353

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


INTRODUCTION

Vanishing white matter disease (VWM, OMIM: 603896), an autosomal recessive inherited leukoencephalopathy, is one of the human genetic diseases that directly affect a protein synthesis factor. Clinically, the VWM is classified as congenital, infantile, early childhood, juvenile, and adult type. The early childhood (onset at 2–6 years old) is the most common one. Clinical features of VWM are rapidly neurological deterioration, aggravated by episodes of “stresses” as fever or minor head trauma. Magnetic resonance imaging shows white matter rarefaction and cystic degeneration, which are eventually replaced by fluid-like intensity signal. The disease-causing genes of VWM are EIF2B1, 2, 3, 4, and 5, encoding the five subunits α, β, γ, δ, and ε of eukaryotic initiation factor 2B (eIF2B), respectively.[12] The eIF2B complex is essential for protein synthesis with the function of guanine nucleotide exchange factor (GEF) activity, converting eIF2 from an inactive GDP-bound structure to an active GTP-bound form. Of the five subunits, eIF2Bε is the largest and the most important one, with majority of the mutations reported among all five subunits.[345] The variation in disease severity is extremely wide, which could hardly be explained by genotypic variations.[6] Frameshift mutants that generated truncated protein or mutations that impair eIF2B complex assembly would give rise to a complete loss of eIF2B function, which seriously affected eIF2B function.[67] The pathogenesis of the disease remains poorly understood. Previous studies demonstrated endoplasmic reticulum stress (ERS) participated in the pathogenesis of VWM,[8] and over-activated unfolded protein response (UPR) was found in VWM brain tissues.[9] Autophagy is a cellular compensatory pathway for the elimination of unfolded protein. In the present study, apoptosis and cell viability in the condition of ERS, activating transcription factor 4 (ATF4) (UPR biomarker) and light chain 3 (LC3) turnover (marker of autophagy) were detected in human oligodendrocyte cell line transfected with missense, deletion or truncated mutations that influence eIF2Bε function at different degrees. The correlation of genotypes and ERS tolerance as well as the compensatory pathways was studied.

METHODS

Cell culture and endoplasmic reticulum stress inducement

MO3.13, a human oligodendrocyte cell line, was purchased from Cellutions Biosystems Corporation (Toronto, Ontario, Canada). The oligodendrocytes were cultured in Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum (GIBCO Invitrogen, Carlsbad, CA, USA) in a humidified atmosphere containing 5% CO2 at 37°C. Oligodendrocytes were cultured in the presence of Thapsigargin (TG) (#T9033, Sigma-Aldrich, USA) 1 μmol/L for ERS induction.

Expression vectors and lentiviral transduction

Lentiviral vector containing Ubi-gene-5’FLAG-IRES-puromycin (GeneChem Corporation, Shanghai, China) was applied for construction of a wild-type full-length EIF2B5 (NM_003907), truncated mutation c. 805C>T (p. Arg269*), deletion c. 1827-1838del (p. Ser610-Asp613del) and a missense mutation c. 338G>A (p. Arg113His). Transfection efficiency was validated with Western blot for FLAG-tag, real-time PCR for transcription, and observation of green fluorescent protein in the blank vector. The mutant or wild-type plasmids were transfected into human oligodendrocytes with an optimized condition and polybrene (5 μg/ml) (GeneChem Corporation), a chemical to enhance the efficiency of transfection. Seventy-two hours after transfection, the cells were harvested for the following studies.

Detection of endoplasmic reticulum stress tolerance

Rates of apoptosis and cell viability were detected by AnnexinV-FITC and quantitated by flow cytometry (FCM). FCM detects the rates of cell apoptosis at 48 h after ERS induction or under baseline condition (spontaneous culture without TG). Oligodendrocytes were double-labeled with AnnexinV-FITC/propidium iodide (PI) by an Apoptosis Detection Kit (KeyGEN BioTECH, Beijing, China). PI was used for exclusion of the nonapoptotic cell death. Oligodendrocytes transfected with a blank plasmid was set as background. Apoptotic rate of oligodendrocytes transfected with the cDNA of wild type (Wt), c. 338G>A, c. 1827-1838del or c. 805C>T was measured as a relative scale to the blank control. Cell viability was measured at different time points after ERS induction with the Cell Counting Kit-8 (Dojindo Laboratories, Kumamoto, Japan). Each assay was repeated three times independently.

Detection of unfolded protein response biomarker

Activating transcription factor 4 is an important component of UPR-PERK pathway. ATF4 could be stimulated from ERS activation indirectly or protein synthesis attenuation by eIF2B mutation directly. ATF4 was determined in human oligodendrocytes transfected with cDNAs of a Wt or mutant eIF2Bε at basal condition and after ERS induction, detected by Western blot with an antibody against ATF4 full-length protein (#ab23760, Cambridge, England).

Detection of autophagy flux

Autophagy flux reflected an integrated autophagy level. It was measured following the recommendations described by Klionsky et al.[10] LC3-II is the activated form of LC3 (microtubule-associated protein 1 LC3), which maintains the stability of autophagosome by inserting into the extending autophagosome membrane. LC3-II turnover assay (cat #2775, Cell Signaling Technology, USA) with lysosomal inhibitors is taken as the classic measurement for analyzing autophagy level. It was monitored 48 h under baseline condition, and ERS induction in human oligodendrocytes transfected with the Wt or mutant cDNAs. Cells were incubated with three lysosomal inhibitors of Bafilomycin A1 (cat #B1793, Sigma-Aldrich), 200 nmol/L; #P5318 Pepstatin A, 10 μg/ml; and #E8640 E64d, 10 μg/ml for 30 min before ERS stimulation. The rate of LC3-II versus β-actin (Santa Cruz Biotechnology, USA) was quantified.

Statistics analysis

All assays described above were repeated independently three times. Representative FCM, Western blots and quantitative evaluations of those markers were expressed as means ± standard deviation. Statistical differences between two groups were determined by two-tailed unpaired t-test. One-way analysis of variance was for more than two groups. P < 0.05 was considered significantly different.

RESULTS

Oligodendrocytes with truncated or deletion mutants in eukaryotic initiation factor 2Bε are less tolerable to endoplasmic reticulum stress

Apoptosis and cell viability assays were performed for the determination of ERS tolerance under baseline condition and ERS induction. Apoptosis rates were tested 48 h in the presence or absence of ERS induction. FCM detected AnnexinV-FITC/PI double-labeled human oligodendrocytes transfected with empty vector, wild-type, and mutations of p. Arg113His (R113H), p. Ser610-Asp613del (Del) and p. Arg269* (R269*). Under a condition without induction of ERS by TG, only the oligodendrocytes transfected with mutation p. Arg269* was undergoing spontaneous apoptosis (t = 4.01, P < 0.05) [Figure 1a, 1c]. When ERS was induced, compared to the cells transfected with the Wt cDNA, oligodendrocytes with mutation p. Arg269* or p. Ser610-Asp613del exhibited higher apoptosis level (p. Arg269* vs. Wt, t = 8.33, P < 0.01; p. Ser610-Asp613del vs. Wt, t = 11.27, P < 0.001), but no significant difference was detected for the mutation p. Arg113His [Figure 1b, 1d].
Figure 1

Cell apoptosis rates in human oligodendrocyte cell line transfected with empty vector (Con), wild-type (Wt), and mutants of p. Arg113His (R113H), p. Ser610-Asp613del (Del) and p. Arg269* (R269*) at 48 h in the presence (b) or absence (a) of TG 1 μmol/L. *P < 0.05, p. Arg269* versus wild-type (Wt); †P < 0.01, p. Arg269* versus Wt; ‡P < 0.001, p. Ser610-Asp613del versus wild-type.

Cell apoptosis rates in human oligodendrocyte cell line transfected with empty vector (Con), wild-type (Wt), and mutants of p. Arg113His (R113H), p. Ser610-Asp613del (Del) and p. Arg269* (R269*) at 48 h in the presence (b) or absence (a) of TG 1 μmol/L. *P < 0.05, p. Arg269* versus wild-type (Wt); †P < 0.01, p. Arg269* versus Wt; ‡P < 0.001, p. Ser610-Asp613del versus wild-type. Different groups of oligodendrocytes were seeded evenly. The primary cell count is 100% and proliferated at 8 h after ERS induction. Oligodendrocytes transfected with mutation p. Arg269* showed reduction in proliferation at 8 h than other groups (F = 17.8, P < 0.01) [Figure 2]. Compared with the Wt, cell viability decreased in cells transfected with the mutations at 24 h after ERS stimulation (F = 37.8, P < 0.01). Oligodendrocytes carrying p. Arg269* showed the most significantly decreased cell viability (t = 5.44, P < 0.01), followed by cells carrying p. Ser610-Asp613del (t = 6.96, P < 0.05), both compared to that carrying p. Arg113His. Same tendency was shown at 48 h after ERS (Wt vs. mutational group: F = 24.9, P < 0.001; p. Arg269* vs. p. Arg113His: t = 10.32, P < 0.001; p. Ser610-Asp613del vs. p. Arg113His, t = 5.84, P < 0.01). No difference was found among cells carrying p. Arg113His, empty vector (Con) or Wt during the whole ERS status [Figure 2].
Figure 2

Endoplasmic reticulum stress induced viability declination. At 8 h: *P < 0.01, the p. Arg269* group versus others. At 24 and 48 h: The wild type versus mutant groups (†24 h: P < 0.01; ‡48 h: P < 0.001); the p. Arg269* versus p. Arg113His (§24 h: P < 0.01; ǀǀ48 h: P < 0.001); the p. Ser610-Asp613del versus p. Arg113His (¶24 h: P < 0.05; **48 h: P < 0.01).

Endoplasmic reticulum stress induced viability declination. At 8 h: *P < 0.01, the p. Arg269* group versus others. At 24 and 48 h: The wild type versus mutant groups (†24 h: P < 0.01; ‡48 h: P < 0.001); the p. Arg269* versus p. Arg113His (§24 h: P < 0.01; ǀǀ48 h: P < 0.001); the p. Ser610-Asp613del versus p. Arg113His (¶24 h: P < 0.05; **48 h: P < 0.01).

Over activated activating transcription factor 4 (unfolded protein response component) in oligodendrocytes with eukaryotic initiation factor 2Bε truncated or deletion mutants

The expression of ATF4 stayed at a higher level in oligodendrocytes transfected with p. Arg269* or p. Ser610-Asp613del at 48 h under spontaneous culture (Arg269* vs. Wt, t = 5.43, P < 0.05; p. Ser610-Asp613del vs. Wt, t = 9.34, P < 0.05) [Figure 3a and c]. At 48 h under ERS induction, ATF4 increased the same escalating trend. ATF4 expressed higher in p. Arg269* and p. Ser610-Asp613del, compared with p. Arg113His transfected cells (Arg269* vs. R113H, t = 4.5, P < 0.05; Del vs. R113H t = 14.59, P < 0.05) [Figure 3b and d].
Figure 3

Activating transcription factor 4 (ATF4) was measured in human oligodendrocyte cell line at 48 h under baseline (a and c) or after endoplasmic reticulum stress stimulation (b and d) by western blot. Levels of ATF4 were compared between groups by t-test of variance analysis. *P < 0.05, the mutations of p. Arg269* (R269*) versus the wild type (Wt); †P < 0.05, p. Ser610-Asp613del (Del) versus the Wt; ‡P < 0.05, p. Arg269* versus p. Arg113His (R113H); §P < 0.05, p. Ser610-Asp613del versus p. Arg113His.

Activating transcription factor 4 (ATF4) was measured in human oligodendrocyte cell line at 48 h under baseline (a and c) or after endoplasmic reticulum stress stimulation (b and d) by western blot. Levels of ATF4 were compared between groups by t-test of variance analysis. *P < 0.05, the mutations of p. Arg269* (R269*) versus the wild type (Wt); †P < 0.05, p. Ser610-Asp613del (Del) versus the Wt; ‡P < 0.05, p. Arg269* versus p. Arg113His (R113H); §P < 0.05, p. Ser610-Asp613del versus p. Arg113His.

Depressed autophagy flux in oligodendrocytes with eukaryotic initiation factor 2Bε truncated or deletion mutants

Autophagy flux was measured by LC3-II turnover assay in the presence of Bafilomycin A1, Pepstatin A, and E64d at 48 h under basal and ERS condition. Autophagy flux was analyzed by measuring the rates of LC3-II versus β-actin. Increased transformation of LC3-II was observed in oligodendrocytes transfected with empty vector or Wt after ERS induction, but not in cells transfected with mutations (F = 46.3, P < 0.001, difference from the mutants and wild-type) [Figure 4]. Both LC3-I and LC3-II expressed at a lower level in the mutants transfected oligodendrocytes after ERS induction. When compared between the three mutation types, LC3-II was lower in cells transfected with the p. Arg269* or p. Ser610-Asp613del, compared with the p. Arg113His after ERS induction (p. Arg269* vs. p. Arg113His t = 5.06, P < 0.05; p. Ser610-Asp613del vs. p. Arg113His, t = 5.81, P < 0.05) [Figure 4b and d]. In spontaneous culture (without ERS induction), LC3-II transformation was higher in cells transfected with p. Arg269* but lower in other mutant expressions (t = 4.43, P < 0.05) [Figure 4a and c].
Figure 4

LC3-II turnover assay showed levels of autophagy flux in oligodendrocytes transfected with different mutants under basal condition (a and c) or endoplasmic reticulum stress inducement (b and d) in the presence of Lysosomal inhibitors: Bafilomycin A1, Pepstatin A, and E64d. *P < 0.05, p. Arg269* (R269*) versus the wild type (Wt); †P < 0.05, p. Ser610-Asp613del (Del) versus the Wt; ‡P < 0.05, p. Arg113His (R113H) versus the Wt; §P < 0.001, the mutations versus the Wt; ǀǀP < 0.05, p. Arg269* versus p. Arg113His (R113H); ¶P < 0.05, p. Ser610-Asp613del versus p. Arg113His.

LC3-II turnover assay showed levels of autophagy flux in oligodendrocytes transfected with different mutants under basal condition (a and c) or endoplasmic reticulum stress inducement (b and d) in the presence of Lysosomal inhibitors: Bafilomycin A1, Pepstatin A, and E64d. *P < 0.05, p. Arg269* (R269*) versus the wild type (Wt); †P < 0.05, p. Ser610-Asp613del (Del) versus the Wt; ‡P < 0.05, p. Arg113His (R113H) versus the Wt; §P < 0.001, the mutations versus the Wt; ǀǀP < 0.05, p. Arg269* versus p. Arg113His (R113H); ¶P < 0.05, p. Ser610-Asp613del versus p. Arg113His.

DISCUSSION

The complex of eIF2B is widely expressed in eukaryotic cells and essential for protein synthesis initiation. Assembled eIF2B converts eIF2 from an inactive GDP-bound form to an active GTP-bound form.[3] Gene defects in any subunits of eIF2Bα, β, γ, δ, and ε cause VWM. eIF2Bε is the largest and the major catalytic GEF domain. Mutations in eIF2B impaired stability of catalytic function and interaction with eIF2.[11] Though eIF2B expresses in all body cells, glial cells are selectively involved in VWM. Oligodendrocytes with a heavy protein-folding load in ER are believed to be susceptible to ERS.[12131415] It remains unknown how the impaired eIF2B activity affects the destiny of oligodendrocyte and explains this devastating disorder. Mutation that affected the amount of eIF2B polypeptides or impair the assembly of eIF2B complex would give rise to a complete loss of eIF2B function. Impaired GEF activity varies in different mutations of eIF2Bε.[161718] Frameshifts or nonsense mutations generate truncated eIF2Bε with serious loss of GEF activity. In our previous study, the truncated mutant (p. Arg269*) and deletion (p. Ser610-Asp613del) that were transfected human embryonic kidney 293 (HEK 293) cells showed a complete loss of GEF functions,[19] whereas p. Arg113His confers nearly 50% loss of functions.[20] Whether the degree of ERS tolerance varies in different polypeptides caused by the missense mutation p. Arg113H is truncated mutant of p. Arg269* or deletion mutant of p. Ser610-Asp613del is an open question. In the present study, apoptosis and cell viability assay were to reflect ERS tolerance in oligodendrocytes transfected with the different mutant types. The truncated or deletion mutant showed less tolerable to ERS than the missense mutant. The p. Arg269* or p. Ser610-Asp613del transfected cells experienced prominent apoptosis increase after ERS stimulation. The p. Arg269*-transfected cells underwent spontaneous apoptosis, even at the baseline condition (without ERS inducement). Cell viability decreased more rapidly in p. Arg269* transfected cells. This suggested that mutations with a more severe impact on GEF activity of eIF2Bε would lead to less tolerance to ERS in oligodendrocytes. Our next question is what potential mechanisms result in susceptibility to ERS? Intracellular pathways respond to ERS include UPR and autophagy. Previous studies indicated elevated UPR biomarkers in the brain autopsy samples,[89] fibroblasts[21] or lymphoblasts[22] from VWM patients. UPR pathway is triggered after ERS induction, beginning with the dissociation of GRP78 from PERK. The dissociated PERK promotes eIF2α phosphorylation. Phosphorylated eIF2α (P-eIF2α) inhibits eIF2B activity to relieve ERS through protein synthesis attenuation. Some stress-induced transcriptors as ATF4 are exempt from the inhibition through specific features in their 5’untranslated regions. ATF4 mRNA is specifically translated, followed by the trans-activation of the cascade ERS target genes, leading to programmed cell death.[2324] How the loss of function in eIF2B explains the elevated UPR components is not fully understood. This may because the increased P-eIF2α potential. Impaired eIF2B activity blocks the transformation from eIF2 to eIF2-GTP. Abundant P-eIF2α molecules are generated from the retained eIF2 factors, followed by the activation of ATF4 under the basal condition and over activated after ERS. In the current study, we measured the expression of ATF4 in oligodendrocytes transfected with different mutants. ATF4 expressed at a higher level in p. Arg269* and p. Ser610-Asp613del transfected cells at baseline and ERS conditions, which means an over-activated UPR-PERK pathway in oligodendrocytes transfected with the truncated or deletion mutant. Autophagy relieves ERS by delivering the unfolded protein to the lysosome for degradation. The protective role of autophagy has been identified in several unfolded protein accumulating disorders in the nervous system, such as Alzheimer's disease, Huntington's disease, multiple system atrophy, amyotrophic lateral sclerosis, and neuronal ceroid lipofuscinosis.[25262728] In our previous research, level of autophagy flux was found depressed in oligodendrocytes transfected with the EIF2B3 mutation compared with the Wt after ERS induction (unpublished data). Whether autophagy level varies in different genotypes of VWM was not analyzed. LC3, expressed in most cell types, is an effective autophagy-testing marker because the synthesis and process of LC3 are increased after autophagy activation.[29] Several autophagy-related genes (Atgs) participated in the LC3 processing. LC3 is encoded by the mammalian homolog of Atg8. Atg4 promoted the cleavage of LC3 to LC3-I after autophagy activation. LC3-II is the membrane bounding form of LC3-I. Atg3 and Atg7 participated in the transformation of LC3-II from LC3-I. In the present study, both of LC3-1 and LC3-II were found depressed in the mutant cells after ERS inducement, which indicated a damaged reactive autophagy flux and the probable impairment of the expression of Atgs. Truncated or deletion mutant exhibited a lower LC3-I and II expression than the missense mutation, which could explain the ERS susceptibility. Under baseline condition, LC3-II turnover was elevated slightly in the p. Arg269* group. It may because the spontaneous apoptosis triggered autophagy degradation in the p. Arg269* group. The autophagic regulation needs to be further studied to explain the difference in autophagy ability with different mutants. In conclusion, the severity of ERS intolerance was related to the degree of function loss in eIF2Bε with different mutants. The truncated mutant of p. Arg269* or deletion mutant p. Ser610-Asp613del transfected human oligodendrocytes cell line experienced more obvious apoptosis as well as elevated UPR and depressed autophagy level. The above findings suggested that different impacts on eIF2B polypeptides generated by missense or preliminary terminated mutants resulted in various degrees of ERS susceptibility and stress related compensatory ways as UPR and autophagy pathways. The comparisons between different mutants may provide a better insight into the genotype and pathogenesis correlation analysis. An intact eIF2B function may assist to strength cell resistant ability to ERS in oligodendrocytes.
  29 in total

Review 1.  Protein folding stress in neurodegenerative diseases: a glimpse into the ER.

Authors:  Soledad Matus; Laurie H Glimcher; Claudio Hetz
Journal:  Curr Opin Cell Biol       Date:  2011-01-31       Impact factor: 8.382

2.  Genotype-phenotype correlation in vanishing white matter disease.

Authors:  H D W van der Lei; C G M van Berkel; W N van Wieringen; C Brenner; A Feigenbaum; S Mercimek-Mahmutoglu; M Philippart; B Tatli; E Wassmer; G C Scheper; M S van der Knaap
Journal:  Neurology       Date:  2010-10-26       Impact factor: 9.910

Review 3.  ER stress-induced cell death mechanisms.

Authors:  Renata Sano; John C Reed
Journal:  Biochim Biophys Acta       Date:  2013-07-10

Review 4.  Autophagy: cellular and molecular mechanisms.

Authors:  Danielle Glick; Sandra Barth; Kay F Macleod
Journal:  J Pathol       Date:  2010-05       Impact factor: 7.996

5.  Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes.

Authors:  Lisa Schwarz; Olaf Goldbaum; Markus Bergmann; Stefan Probst-Cousin; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2012-03-13       Impact factor: 3.444

6.  Functional analysis of recently identified mutations in eukaryotic translation initiation factor 2Bɛ (eIF2Bɛ) identified in Chinese patients with vanishing white matter disease.

Authors:  Xuerong Leng; Ye Wu; Xuemin Wang; Yanxia Pan; Jingmin Wang; Jiao Li; Li Du; Lifang Dai; Xiru Wu; Christopher G Proud; Yuwu Jiang
Journal:  J Hum Genet       Date:  2011-02-10       Impact factor: 3.172

7.  Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients.

Authors:  Laetitia Horzinski; Liraz Kantor; Aurélia Huyghe; Raphael Schiffmann; Orna Elroy-Stein; Odile Boespflug-Tanguy; Anne Fogli
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

8.  Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.

Authors:  Marianna Bugiani; Nienke Postma; Emiel Polder; Nikki Dieleman; Peter G Scheffer; Fraser J Sim; Marjo S van der Knaap; Ilja Boor
Journal:  Brain       Date:  2013-01       Impact factor: 13.501

9.  Guidelines for the use and interpretation of assays for monitoring autophagy.

Authors:  Daniel J Klionsky; Fabio C Abdalla; Hagai Abeliovich; Robert T Abraham; Abraham Acevedo-Arozena; Khosrow Adeli; Lotta Agholme; Maria Agnello; Patrizia Agostinis; Julio A Aguirre-Ghiso; Hyung Jun Ahn; Ouardia Ait-Mohamed; Slimane Ait-Si-Ali; Takahiko Akematsu; Shizuo Akira; Hesham M Al-Younes; Munir A Al-Zeer; Matthew L Albert; Roger L Albin; Javier Alegre-Abarrategui; Maria Francesca Aleo; Mehrdad Alirezaei; Alexandru Almasan; Maylin Almonte-Becerril; Atsuo Amano; Ravi Amaravadi; Shoba Amarnath; Amal O Amer; Nathalie Andrieu-Abadie; Vellareddy Anantharam; David K Ann; Shailendra Anoopkumar-Dukie; Hiroshi Aoki; Nadezda Apostolova; Giuseppe Arancia; John P Aris; Katsuhiko Asanuma; Nana Y O Asare; Hisashi Ashida; Valerie Askanas; David S Askew; Patrick Auberger; Misuzu Baba; Steven K Backues; Eric H Baehrecke; Ben A Bahr; Xue-Yuan Bai; Yannick Bailly; Robert Baiocchi; Giulia Baldini; Walter Balduini; Andrea Ballabio; Bruce A Bamber; Edward T W Bampton; Gábor Bánhegyi; Clinton R Bartholomew; Diane C Bassham; Robert C Bast; Henri Batoko; Boon-Huat Bay; Isabelle Beau; Daniel M Béchet; Thomas J Begley; Christian Behl; Christian Behrends; Soumeya Bekri; Bryan Bellaire; Linda J Bendall; Luca Benetti; Laura Berliocchi; Henri Bernardi; Francesca Bernassola; Sébastien Besteiro; Ingrid Bhatia-Kissova; Xiaoning Bi; Martine Biard-Piechaczyk; Janice S Blum; Lawrence H Boise; Paolo Bonaldo; David L Boone; Beat C Bornhauser; Karina R Bortoluci; Ioannis Bossis; Frédéric Bost; Jean-Pierre Bourquin; Patricia Boya; Michaël Boyer-Guittaut; Peter V Bozhkov; Nathan R Brady; Claudio Brancolini; Andreas Brech; Jay E Brenman; Ana Brennand; Emery H Bresnick; Patrick Brest; Dave Bridges; Molly L Bristol; Paul S Brookes; Eric J Brown; John H Brumell; Nicola Brunetti-Pierri; Ulf T Brunk; Dennis E Bulman; Scott J Bultman; Geert Bultynck; Lena F Burbulla; Wilfried Bursch; Jonathan P Butchar; Wanda Buzgariu; Sergio P Bydlowski; Ken Cadwell; Monika Cahová; Dongsheng Cai; Jiyang Cai; Qian Cai; Bruno Calabretta; Javier Calvo-Garrido; Nadine Camougrand; Michelangelo Campanella; Jenny Campos-Salinas; Eleonora Candi; Lizhi Cao; Allan B Caplan; Simon R Carding; Sandra M Cardoso; Jennifer S Carew; Cathleen R Carlin; Virginie Carmignac; Leticia A M Carneiro; Serena Carra; Rosario A Caruso; Giorgio Casari; Caty Casas; Roberta Castino; Eduardo Cebollero; Francesco Cecconi; Jean Celli; Hassan Chaachouay; Han-Jung Chae; Chee-Yin Chai; David C Chan; Edmond Y Chan; Raymond Chuen-Chung Chang; Chi-Ming Che; Ching-Chow Chen; Guang-Chao Chen; Guo-Qiang Chen; Min Chen; Quan Chen; Steve S-L Chen; WenLi Chen; Xi Chen; Xiangmei Chen; Xiequn Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Zhixiang Chen; Alan Cheng; Christopher H K Cheng; Yan Cheng; Heesun Cheong; Jae-Ho Cheong; Sara Cherry; Russ Chess-Williams; Zelda H Cheung; Eric Chevet; Hui-Ling Chiang; Roberto Chiarelli; Tomoki Chiba; Lih-Shen Chin; Shih-Hwa Chiou; Francis V Chisari; Chi Hin Cho; Dong-Hyung Cho; Augustine M K Choi; DooSeok Choi; Kyeong Sook Choi; Mary E Choi; Salem Chouaib; Divaker Choubey; Vinay Choubey; Charleen T Chu; Tsung-Hsien Chuang; Sheau-Huei Chueh; Taehoon Chun; Yong-Joon Chwae; Mee-Len Chye; Roberto Ciarcia; Maria R Ciriolo; Michael J Clague; Robert S B Clark; Peter G H Clarke; Robert Clarke; Patrice Codogno; Hilary A Coller; María I Colombo; Sergio Comincini; Maria Condello; Fabrizio Condorelli; Mark R Cookson; Graham H Coombs; Isabelle Coppens; Ramon Corbalan; Pascale Cossart; Paola Costelli; Safia Costes; Ana Coto-Montes; Eduardo Couve; Fraser P Coxon; James M Cregg; José L Crespo; Marianne J Cronjé; Ana Maria Cuervo; Joseph J Cullen; Mark J Czaja; Marcello D'Amelio; Arlette Darfeuille-Michaud; Lester M Davids; Faith E Davies; Massimo De Felici; John F de Groot; Cornelis A M de Haan; Luisa De Martino; Angelo De Milito; Vincenzo De Tata; Jayanta Debnath; Alexei Degterev; Benjamin Dehay; Lea M D Delbridge; Francesca Demarchi; Yi Zhen Deng; Jörn Dengjel; Paul Dent; Donna Denton; Vojo Deretic; Shyamal D Desai; Rodney J Devenish; Mario Di Gioacchino; Gilbert Di Paolo; Chiara Di Pietro; Guillermo Díaz-Araya; Inés Díaz-Laviada; Maria T Diaz-Meco; Javier Diaz-Nido; Ivan Dikic; Savithramma P Dinesh-Kumar; Wen-Xing Ding; Clark W Distelhorst; Abhinav Diwan; Mojgan Djavaheri-Mergny; Svetlana Dokudovskaya; Zheng Dong; Frank C Dorsey; Victor Dosenko; James J Dowling; Stephen Doxsey; Marlène Dreux; Mark E Drew; Qiuhong Duan; Michel A Duchosal; Karen Duff; Isabelle Dugail; Madeleine Durbeej; Michael Duszenko; Charles L Edelstein; Aimee L Edinger; Gustavo Egea; Ludwig Eichinger; N Tony Eissa; Suhendan Ekmekcioglu; Wafik S El-Deiry; Zvulun Elazar; Mohamed Elgendy; Lisa M Ellerby; Kai Er Eng; Anna-Mart Engelbrecht; Simone Engelender; Jekaterina Erenpreisa; Ricardo Escalante; Audrey Esclatine; Eeva-Liisa Eskelinen; Lucile Espert; Virginia Espina; Huizhou Fan; Jia Fan; Qi-Wen Fan; Zhen Fan; Shengyun Fang; Yongqi Fang; Manolis Fanto; Alessandro Fanzani; Thomas Farkas; Jean-Claude Farré; Mathias Faure; Marcus Fechheimer; Carl G Feng; Jian Feng; Qili Feng; Youji Feng; László Fésüs; Ralph Feuer; Maria E Figueiredo-Pereira; Gian Maria Fimia; Diane C Fingar; Steven Finkbeiner; Toren Finkel; Kim D Finley; Filomena Fiorito; Edward A Fisher; Paul B Fisher; Marc Flajolet; Maria L Florez-McClure; Salvatore Florio; Edward A Fon; Francesco Fornai; Franco Fortunato; Rati Fotedar; Daniel H Fowler; Howard S Fox; Rodrigo Franco; Lisa B Frankel; Marc Fransen; José M Fuentes; Juan Fueyo; Jun Fujii; Kozo Fujisaki; Eriko Fujita; Mitsunori Fukuda; Ruth H Furukawa; Matthias Gaestel; Philippe Gailly; Malgorzata Gajewska; Brigitte Galliot; Vincent Galy; Subramaniam Ganesh; Barry Ganetzky; Ian G Ganley; Fen-Biao Gao; George F Gao; Jinming Gao; Lorena Garcia; Guillermo Garcia-Manero; Mikel Garcia-Marcos; Marjan Garmyn; Andrei L Gartel; Evelina Gatti; Mathias Gautel; Thomas R Gawriluk; Matthew E Gegg; Jiefei Geng; Marc Germain; Jason E Gestwicki; David A Gewirtz; Saeid Ghavami; Pradipta Ghosh; Anna M Giammarioli; Alexandra N Giatromanolaki; Spencer B Gibson; Robert W Gilkerson; Michael L Ginger; Henry N Ginsberg; Jakub Golab; Michael S Goligorsky; Pierre Golstein; Candelaria Gomez-Manzano; Ebru Goncu; Céline Gongora; Claudio D Gonzalez; Ramon Gonzalez; Cristina González-Estévez; Rosa Ana González-Polo; Elena Gonzalez-Rey; Nikolai V Gorbunov; Sharon Gorski; Sandro Goruppi; Roberta A Gottlieb; Devrim Gozuacik; Giovanna Elvira Granato; Gary D Grant; Kim N Green; Aleš Gregorc; Frédéric Gros; Charles Grose; Thomas W Grunt; Philippe Gual; Jun-Lin Guan; Kun-Liang Guan; Sylvie M Guichard; Anna S Gukovskaya; Ilya Gukovsky; Jan Gunst; Asa B Gustafsson; Andrew J Halayko; Amber N Hale; Sandra K Halonen; Maho Hamasaki; Feng Han; Ting Han; Michael K Hancock; Malene Hansen; Hisashi Harada; Masaru Harada; Stefan E Hardt; J Wade Harper; Adrian L Harris; James Harris; Steven D Harris; Makoto Hashimoto; Jeffrey A Haspel; Shin-ichiro Hayashi; Lori A Hazelhurst; Congcong He; You-Wen He; Marie-Joseé Hébert; Kim A Heidenreich; Miep H Helfrich; Gudmundur V Helgason; Elizabeth P Henske; Brian Herman; Paul K Herman; Claudio Hetz; Sabine Hilfiker; Joseph A Hill; Lynne J Hocking; Paul Hofman; Thomas G Hofmann; Jörg Höhfeld; Tessa L Holyoake; Ming-Huang Hong; David A Hood; Gökhan S Hotamisligil; Ewout J Houwerzijl; Maria Høyer-Hansen; Bingren Hu; Chien-An A Hu; Hong-Ming Hu; Ya Hua; Canhua Huang; Ju Huang; Shengbing Huang; Wei-Pang Huang; Tobias B Huber; Won-Ki Huh; Tai-Ho Hung; Ted R Hupp; Gang Min Hur; James B Hurley; Sabah N A Hussain; Patrick J Hussey; Jung Jin Hwang; Seungmin Hwang; Atsuhiro Ichihara; Shirin Ilkhanizadeh; Ken Inoki; Takeshi Into; Valentina Iovane; Juan L Iovanna; Nancy Y Ip; Yoshitaka Isaka; Hiroyuki Ishida; Ciro Isidoro; Ken-ichi Isobe; Akiko Iwasaki; Marta Izquierdo; Yotaro Izumi; Panu M Jaakkola; Marja Jäättelä; George R Jackson; William T Jackson; Bassam Janji; Marina Jendrach; Ju-Hong Jeon; Eui-Bae Jeung; Hong Jiang; Hongchi Jiang; Jean X Jiang; Ming Jiang; Qing Jiang; Xuejun Jiang; Xuejun Jiang; Alberto Jiménez; Meiyan Jin; Shengkan Jin; Cheol O Joe; Terje Johansen; Daniel E Johnson; Gail V W Johnson; Nicola L Jones; Bertrand Joseph; Suresh K Joseph; Annie M Joubert; Gábor Juhász; Lucienne Juillerat-Jeanneret; Chang Hwa Jung; Yong-Keun Jung; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Motoni Kadowaki; Katarina Kagedal; Yoshiaki Kamada; Vitaliy O Kaminskyy; Harm H Kampinga; Hiromitsu Kanamori; Chanhee Kang; Khong Bee Kang; Kwang Il Kang; Rui Kang; Yoon-A Kang; Tomotake Kanki; Thirumala-Devi Kanneganti; Haruo Kanno; Anumantha G Kanthasamy; Arthi Kanthasamy; Vassiliki Karantza; Gur P Kaushal; Susmita Kaushik; Yoshinori Kawazoe; Po-Yuan Ke; John H Kehrl; Ameeta Kelekar; Claus Kerkhoff; David H Kessel; Hany Khalil; Jan A K W Kiel; Amy A Kiger; Akio Kihara; Deok Ryong Kim; Do-Hyung Kim; Dong-Hou Kim; Eun-Kyoung Kim; Hyung-Ryong Kim; Jae-Sung Kim; Jeong Hun Kim; Jin Cheon Kim; John K Kim; Peter K Kim; Seong Who Kim; Yong-Sun Kim; Yonghyun Kim; Adi Kimchi; Alec C Kimmelman; Jason S King; Timothy J Kinsella; Vladimir Kirkin; Lorrie A Kirshenbaum; Katsuhiko Kitamoto; Kaio Kitazato; Ludger Klein; Walter T Klimecki; Jochen Klucken; Erwin Knecht; Ben C B Ko; Jan C Koch; Hiroshi Koga; Jae-Young Koh; Young Ho Koh; Masato Koike; Masaaki Komatsu; Eiki Kominami; Hee Jeong Kong; Wei-Jia Kong; Viktor I Korolchuk; Yaichiro Kotake; Michael I Koukourakis; Juan B Kouri Flores; Attila L Kovács; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Carole Kretz-Remy; Anna M Krichevsky; Guido Kroemer; Rejko Krüger; Oleg Krut; Nicholas T Ktistakis; Chia-Yi Kuan; Roza Kucharczyk; Ashok Kumar; Raj Kumar; Sharad Kumar; Mondira Kundu; Hsing-Jien Kung; Tino Kurz; Ho Jeong Kwon; Albert R La Spada; Frank Lafont; Trond Lamark; Jacques Landry; Jon D Lane; Pierre Lapaquette; Jocelyn F Laporte; Lajos László; Sergio Lavandero; Josée N Lavoie; Robert Layfield; Pedro A Lazo; Weidong Le; Laurent Le Cam; Daniel J Ledbetter; Alvin J X Lee; Byung-Wan Lee; Gyun Min Lee; Jongdae Lee; Ju-Hyun Lee; Michael Lee; Myung-Shik Lee; Sug Hyung Lee; Christiaan Leeuwenburgh; Patrick Legembre; Renaud Legouis; Michael Lehmann; Huan-Yao Lei; Qun-Ying Lei; David A Leib; José Leiro; John J Lemasters; Antoinette Lemoine; Maciej S Lesniak; Dina Lev; Victor V Levenson; Beth Levine; Efrat Levy; Faqiang Li; Jun-Lin Li; Lian Li; Sheng Li; Weijie Li; Xue-Jun Li; Yan-bo Li; Yi-Ping Li; Chengyu Liang; Qiangrong Liang; Yung-Feng Liao; Pawel P Liberski; Andrew Lieberman; Hyunjung J Lim; Kah-Leong Lim; Kyu Lim; Chiou-Feng Lin; Fu-Cheng Lin; Jian Lin; Jiandie D Lin; Kui Lin; Wan-Wan Lin; Weei-Chin Lin; Yi-Ling Lin; Rafael Linden; Paul Lingor; Jennifer Lippincott-Schwartz; Michael P Lisanti; Paloma B Liton; Bo Liu; Chun-Feng Liu; Kaiyu Liu; Leyuan Liu; Qiong A Liu; Wei Liu; Young-Chau Liu; Yule Liu; Richard A Lockshin; Chun-Nam Lok; Sagar Lonial; Benjamin Loos; Gabriel Lopez-Berestein; Carlos López-Otín; Laura Lossi; Michael T Lotze; Peter Lőw; Binfeng Lu; Bingwei Lu; Bo Lu; Zhen Lu; Frédéric Luciano; Nicholas W Lukacs; Anders H Lund; Melinda A Lynch-Day; Yong Ma; Fernando Macian; Jeff P MacKeigan; Kay F Macleod; Frank Madeo; Luigi Maiuri; Maria Chiara Maiuri; Davide Malagoli; May Christine V Malicdan; Walter Malorni; Na Man; Eva-Maria Mandelkow; Stéphen Manon; Irena Manov; Kai Mao; Xiang Mao; Zixu Mao; Philippe Marambaud; Daniela Marazziti; Yves L Marcel; Katie Marchbank; Piero Marchetti; Stefan J Marciniak; Mateus Marcondes; Mohsen Mardi; Gabriella Marfe; Guillermo Mariño; Maria Markaki; Mark R Marten; Seamus J Martin; Camille Martinand-Mari; Wim Martinet; Marta Martinez-Vicente; Matilde Masini; Paola Matarrese; Saburo Matsuo; Raffaele Matteoni; Andreas Mayer; Nathalie M Mazure; David J McConkey; Melanie J McConnell; Catherine McDermott; Christine McDonald; Gerald M McInerney; Sharon L McKenna; BethAnn McLaughlin; Pamela J McLean; Christopher R McMaster; G Angus McQuibban; Alfred J Meijer; Miriam H Meisler; Alicia Meléndez; Thomas J Melia; Gerry Melino; Maria A Mena; Javier A Menendez; Rubem F S Menna-Barreto; Manoj B Menon; Fiona M Menzies; Carol A Mercer; Adalberto Merighi; Diane E Merry; Stefania Meschini; Christian G Meyer; Thomas F Meyer; Chao-Yu Miao; Jun-Ying Miao; Paul A M Michels; Carine Michiels; Dalibor Mijaljica; Ana Milojkovic; Saverio Minucci; Clelia Miracco; Cindy K Miranti; Ioannis Mitroulis; Keisuke Miyazawa; Noboru Mizushima; Baharia Mograbi; Simin Mohseni; Xavier Molero; Bertrand Mollereau; Faustino Mollinedo; Takashi Momoi; Iryna Monastyrska; Martha M Monick; Mervyn J Monteiro; Michael N Moore; Rodrigo Mora; Kevin Moreau; Paula I Moreira; Yuji Moriyasu; Jorge Moscat; Serge Mostowy; Jeremy C Mottram; Tomasz Motyl; Charbel E-H Moussa; Sylke Müller; Sylviane Muller; Karl Münger; Christian Münz; Leon O Murphy; Maureen E Murphy; Antonio Musarò; Indira Mysorekar; Eiichiro Nagata; Kazuhiro Nagata; Aimable Nahimana; Usha Nair; Toshiyuki Nakagawa; Kiichi Nakahira; Hiroyasu Nakano; Hitoshi Nakatogawa; Meera Nanjundan; Naweed I Naqvi; Derek P Narendra; Masashi Narita; Miguel Navarro; Steffan T Nawrocki; Taras Y Nazarko; Andriy Nemchenko; Mihai G Netea; Thomas P Neufeld; Paul A Ney; Ioannis P Nezis; Huu Phuc Nguyen; Daotai Nie; Ichizo Nishino; Corey Nislow; Ralph A Nixon; Takeshi Noda; Angelika A Noegel; Anna Nogalska; Satoru Noguchi; Lucia Notterpek; Ivana Novak; Tomoyoshi Nozaki; Nobuyuki Nukina; Thorsten Nürnberger; Beat Nyfeler; Keisuke Obara; Terry D Oberley; Salvatore Oddo; Michinaga Ogawa; Toya Ohashi; Koji Okamoto; Nancy L Oleinick; F Javier Oliver; Laura J Olsen; Stefan Olsson; Onya Opota; Timothy F Osborne; Gary K Ostrander; Kinya Otsu; Jing-hsiung James Ou; Mireille Ouimet; Michael Overholtzer; Bulent Ozpolat; Paolo Paganetti; Ugo Pagnini; Nicolas Pallet; Glen E Palmer; Camilla Palumbo; Tianhong Pan; Theocharis Panaretakis; Udai Bhan Pandey; Zuzana Papackova; Issidora Papassideri; Irmgard Paris; Junsoo Park; Ohkmae K Park; Jan B Parys; Katherine R Parzych; Susann Patschan; Cam Patterson; Sophie Pattingre; John M Pawelek; Jianxin Peng; David H Perlmutter; Ida Perrotta; George Perry; Shazib Pervaiz; Matthias Peter; Godefridus J Peters; Morten Petersen; Goran Petrovski; James M Phang; Mauro Piacentini; Philippe Pierre; Valérie Pierrefite-Carle; Gérard Pierron; Ronit Pinkas-Kramarski; Antonio Piras; Natik Piri; Leonidas C Platanias; Stefanie Pöggeler; Marc Poirot; Angelo Poletti; Christian Poüs; Mercedes Pozuelo-Rubio; Mette Prætorius-Ibba; Anil Prasad; Mark Prescott; Muriel Priault; Nathalie Produit-Zengaffinen; Ann Progulske-Fox; Tassula Proikas-Cezanne; Serge Przedborski; Karin Przyklenk; Rosa Puertollano; Julien Puyal; Shu-Bing Qian; Liang Qin; Zheng-Hong Qin; Susan E Quaggin; Nina Raben; Hannah Rabinowich; Simon W Rabkin; Irfan Rahman; Abdelhaq Rami; Georg Ramm; Glenn Randall; Felix Randow; V Ashutosh Rao; Jeffrey C Rathmell; Brinda Ravikumar; Swapan K Ray; Bruce H Reed; John C Reed; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; John J Reiners; Russel J Reiter; Jun Ren; José L Revuelta; Christopher J Rhodes; Konstantinos Ritis; Elizete Rizzo; Jeffrey Robbins; Michel Roberge; Hernan Roca; Maria C Roccheri; Stephane Rocchi; H Peter Rodemann; Santiago Rodríguez de Córdoba; Bärbel Rohrer; Igor B Roninson; Kirill Rosen; Magdalena M Rost-Roszkowska; Mustapha Rouis; Kasper M A Rouschop; Francesca Rovetta; Brian P Rubin; David C Rubinsztein; Klaus Ruckdeschel; Edmund B Rucker; Assaf Rudich; Emil Rudolf; Nelson Ruiz-Opazo; Rossella Russo; Tor Erik Rusten; Kevin M Ryan; Stefan W Ryter; David M Sabatini; Junichi Sadoshima; Tapas Saha; Tatsuya Saitoh; Hiroshi Sakagami; Yasuyoshi Sakai; Ghasem Hoseini Salekdeh; Paolo Salomoni; Paul M Salvaterra; Guy Salvesen; Rosa Salvioli; Anthony M J Sanchez; José A Sánchez-Alcázar; Ricardo Sánchez-Prieto; Marco Sandri; Uma Sankar; Poonam Sansanwal; Laura Santambrogio; Shweta Saran; Sovan Sarkar; Minnie Sarwal; Chihiro Sasakawa; Ausra Sasnauskiene; Miklós Sass; Ken Sato; Miyuki Sato; Anthony H V Schapira; Michael Scharl; Hermann M Schätzl; Wiep Scheper; Stefano Schiaffino; Claudio Schneider; Marion E Schneider; Regine Schneider-Stock; Patricia V Schoenlein; Daniel F Schorderet; Christoph Schüller; Gary K Schwartz; Luca Scorrano; Linda Sealy; Per O Seglen; Juan Segura-Aguilar; Iban Seiliez; Oleksandr Seleverstov; Christian Sell; Jong Bok Seo; Duska Separovic; Vijayasaradhi Setaluri; Takao Setoguchi; Carmine Settembre; John J Shacka; Mala Shanmugam; Irving M Shapiro; Eitan Shaulian; Reuben J Shaw; James H Shelhamer; Han-Ming Shen; Wei-Chiang Shen; Zu-Hang Sheng; Yang Shi; Kenichi Shibuya; Yoshihiro Shidoji; Jeng-Jer Shieh; Chwen-Ming Shih; Yohta Shimada; Shigeomi Shimizu; Takahiro Shintani; Orian S Shirihai; Gordon C Shore; Andriy A Sibirny; Stan B Sidhu; Beata Sikorska; Elaine C M Silva-Zacarin; Alison Simmons; Anna Katharina Simon; Hans-Uwe Simon; Cristiano Simone; Anne Simonsen; David A Sinclair; Rajat Singh; Debasish Sinha; Frank A Sinicrope; Agnieszka Sirko; Parco M Siu; Efthimios Sivridis; Vojtech Skop; Vladimir P Skulachev; Ruth S Slack; Soraya S Smaili; Duncan R Smith; Maria S Soengas; Thierry Soldati; Xueqin Song; Anil K Sood; Tuck Wah Soong; Federica Sotgia; Stephen A Spector; Claudia D Spies; Wolfdieter Springer; Srinivasa M Srinivasula; Leonidas Stefanis; Joan S Steffan; Ruediger Stendel; Harald Stenmark; Anastasis Stephanou; Stephan T Stern; Cinthya Sternberg; Björn Stork; Peter Strålfors; Carlos S Subauste; Xinbing Sui; David Sulzer; Jiaren Sun; Shi-Yong Sun; Zhi-Jun Sun; Joseph J Y Sung; Kuninori Suzuki; Toshihiko Suzuki; Michele S Swanson; Charles Swanton; Sean T Sweeney; Lai-King Sy; Gyorgy Szabadkai; Ira Tabas; Heinrich Taegtmeyer; Marco Tafani; Krisztina Takács-Vellai; Yoshitaka Takano; Kaoru Takegawa; Genzou Takemura; Fumihiko Takeshita; Nicholas J Talbot; Kevin S W Tan; Keiji Tanaka; Kozo Tanaka; Daolin Tang; Dingzhong Tang; Isei Tanida; Bakhos A Tannous; Nektarios Tavernarakis; Graham S Taylor; Gregory A Taylor; J Paul Taylor; Lance S Terada; Alexei Terman; Gianluca Tettamanti; Karin Thevissen; Craig B Thompson; Andrew Thorburn; Michael Thumm; FengFeng Tian; Yuan Tian; Glauco Tocchini-Valentini; Aviva M Tolkovsky; Yasuhiko Tomino; Lars Tönges; Sharon A Tooze; Cathy Tournier; John Tower; Roberto Towns; Vladimir Trajkovic; Leonardo H Travassos; Ting-Fen Tsai; Mario P Tschan; Takeshi Tsubata; Allan Tsung; Boris Turk; Lorianne S Turner; Suresh C Tyagi; Yasuo Uchiyama; Takashi Ueno; Midori Umekawa; Rika Umemiya-Shirafuji; Vivek K Unni; Maria I Vaccaro; Enza Maria Valente; Greet Van den Berghe; Ida J van der Klei; Wouter van Doorn; Linda F van Dyk; Marjolein van Egmond; Leo A van Grunsven; Peter Vandenabeele; Wim P Vandenberghe; Ilse Vanhorebeek; Eva C Vaquero; Guillermo Velasco; Tibor Vellai; Jose Miguel Vicencio; Richard D Vierstra; Miquel Vila; Cécile Vindis; Giampietro Viola; Maria Teresa Viscomi; Olga V Voitsekhovskaja; Clarissa von Haefen; Marcela Votruba; Keiji Wada; Richard Wade-Martins; Cheryl L Walker; Craig M Walsh; Jochen Walter; Xiang-Bo Wan; Aimin Wang; Chenguang Wang; Dawei Wang; Fan Wang; Fen Wang; Guanghui Wang; Haichao Wang; Hong-Gang Wang; Horng-Dar Wang; Jin Wang; Ke Wang; Mei Wang; Richard C Wang; Xinglong Wang; Xuejun Wang; Ying-Jan Wang; Yipeng Wang; Zhen Wang; Zhigang Charles Wang; Zhinong Wang; Derick G Wansink; Diane M Ward; Hirotaka Watada; Sarah L Waters; Paul Webster; Lixin Wei; Conrad C Weihl; William A Weiss; Scott M Welford; Long-Ping Wen; Caroline A Whitehouse; J Lindsay Whitton; Alexander J Whitworth; Tom Wileman; John W Wiley; Simon Wilkinson; Dieter Willbold; Roger L Williams; Peter R Williamson; Bradly G Wouters; Chenghan Wu; Dao-Cheng Wu; William K K Wu; Andreas Wyttenbach; Ramnik J Xavier; Zhijun Xi; Pu Xia; Gengfu Xiao; Zhiping Xie; Zhonglin Xie; Da-zhi Xu; Jianzhen Xu; Liang Xu; Xiaolei Xu; Ai Yamamoto; Akitsugu Yamamoto; Shunhei Yamashina; Michiaki Yamashita; Xianghua Yan; Mitsuhiro Yanagida; Dun-Sheng Yang; Elizabeth Yang; Jin-Ming Yang; Shi Yu Yang; Wannian Yang; Wei Yuan Yang; Zhifen Yang; Meng-Chao Yao; Tso-Pang Yao; Behzad Yeganeh; Wei-Lien Yen; Jia-jing Yin; Xiao-Ming Yin; Ook-Joon Yoo; Gyesoon Yoon; Seung-Yong Yoon; Tomohiro Yorimitsu; Yuko Yoshikawa; Tamotsu Yoshimori; Kohki Yoshimoto; Ho Jin You; Richard J Youle; Anas Younes; Li Yu; Long Yu; Seong-Woon Yu; Wai Haung Yu; Zhi-Min Yuan; Zhenyu Yue; Cheol-Heui Yun; Michisuke Yuzaki; Olga Zabirnyk; Elaine Silva-Zacarin; David Zacks; Eldad Zacksenhaus; Nadia Zaffaroni; Zahra Zakeri; Herbert J Zeh; Scott O Zeitlin; Hong Zhang; Hui-Ling Zhang; Jianhua Zhang; Jing-Pu Zhang; Lin Zhang; Long Zhang; Ming-Yong Zhang; Xu Dong Zhang; Mantong Zhao; Yi-Fang Zhao; Ying Zhao; Zhizhuang J Zhao; Xiaoxiang Zheng; Boris Zhivotovsky; Qing Zhong; Cong-Zhao Zhou; Changlian Zhu; Wei-Guo Zhu; Xiao-Feng Zhu; Xiongwei Zhu; Yuangang Zhu; Teresa Zoladek; Wei-Xing Zong; Antonio Zorzano; Jürgen Zschocke; Brian Zuckerbraun
Journal:  Autophagy       Date:  2012-04       Impact factor: 16.016

Review 10.  Therapeutic induction of autophagy to modulate neurodegenerative disease progression.

Authors:  Warren E Hochfeld; Shirley Lee; David C Rubinsztein
Journal:  Acta Pharmacol Sin       Date:  2013-02-04       Impact factor: 6.150

View more
  5 in total

Review 1.  Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.

Authors:  Benjamin L L Clayton; Brian Popko
Journal:  Brain Res       Date:  2016-04-04       Impact factor: 3.252

2.  GIT2 Acts as a Systems-Level Coordinator of Neurometabolic Activity and Pathophysiological Aging.

Authors:  Bronwen Martin; Wayne Chadwick; Jonathan Janssens; Richard T Premont; Robert Schmalzigaug; Kevin G Becker; Elin Lehrmann; William H Wood; Yongqing Zhang; Sana Siddiqui; Sung-Soo Park; Wei-Na Cong; Caitlin M Daimon; Stuart Maudsley
Journal:  Front Endocrinol (Lausanne)       Date:  2016-01-18       Impact factor: 5.555

3.  Adult mouse eIF2Bε Arg191His astrocytes display a normal integrated stress response in vitro.

Authors:  Lisanne E Wisse; Timo J Ter Braak; Malu-Clair van de Beek; Carola G M van Berkel; Joke Wortel; Vivi M Heine; Chris G Proud; Marjo S van der Knaap; Truus E M Abbink
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

4.  Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction.

Authors:  Ling Zhou; Peng Li; Na Chen; Li-Fang Dai; Kai Gao; Yi-Nan Liu; Li Shen; Jing-Min Wang; Yu-Wu Jiang; Ye Wu
Journal:  CNS Neurosci Ther       Date:  2019-02-05       Impact factor: 5.243

Review 5.  Autophagy in white matter disorders of the CNS: mechanisms and therapeutic opportunities.

Authors:  Erik Nutma; Manuel C Marzin; Saskia Agm Cillessen; Sandra Amor
Journal:  J Pathol       Date:  2020-12-04       Impact factor: 9.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.